BrightSpring Health Services Inc (NASDAQ:BTSG) does about 990.13K shares in volume on a normal day but saw 2212206 shares change hands in the recent trading day. The company now has a market cap of 1.91B USD. Its current market price is $11.16, marking a decrease of -8.75% compared to the previous close of $12.23. The 52 week high reached by this stock is $12.79 whilst the lowest price level in 52 weeks is $7.85.
BrightSpring Health Services Inc (BTSG) has a 20-day trading average at $11.75 and the current price is -12.74% off the 52-week high compared with 42.17% distance from its 52-week low. The 50-day simple moving average of the closing price is $11.33. If we look at the stock’s price movements over the week, volatility stands at 5.08%, which decreases to 3.38% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 41.82 to suggest the stock is neutral.
The consensus objective for the share price is $16.00, suggesting that the stock has a potential upside of 30.25% over the period.
2 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on June 21, 2024 when BTIG Research initiated the stock to “Buy” and issued a price target of $15. Deutsche Bank upgraded its price target at $11.50.
BrightSpring Health Services Inc (BTSG) stock is down -9.49% over the week and -1.33% over the past month. Its price is 1.45% year-to-date.
The stock last released its quarterly earnings report for quarter ended 6/30/2024, with the company’s earnings per share (EPS) of 0.14 above consensus estimates by 0.05. The company’s next earnings report forecasts estimating quarterly EPS at 0.17 and 0.66 for whole year. Expected sales for next quarter are $2.77B, which analysts say will come at $10.64B for the current fiscal year and next year at $11.6B. In addition, estimates put the company’s current quarterly revenue at an average of $2.66B.
To reach the target analysts have set, the stock logically needs to grow 30.25 percent from here.
The company has a return on investment of -3.72% and return on equity of -13.88%. The forward price to earnings ratio is 13.45. Price to book ratio is 1.20 and price to sales ratio is 0.19.
